Showing posts with label non-metastatic castration resistant prostate cancer (nmCRPC). Show all posts
Showing posts with label non-metastatic castration resistant prostate cancer (nmCRPC). Show all posts
Sunday, July 29, 2012

Takeda announces updated results from orteronel phase 2 study on nmCRPC

›
Takeda announces updated results from orteronel phase 2 study on nmCRPC : Millennium: The Takeda Oncology Company with its parent com...